Officers & Advisors
Gina earned her BS in Biochemistry from Rutgers University - New Brunswick in 2017, where her research focused on the thermodynamics and kinetics of protein folding. Currently she is a fourth year PhD student in the Biochemistry and Molecular Pharmacology program. She works in the lab of Dr. Dmitry Temiakov, studying the molecular mechanisms underlying human mitochondrial transcription and replication. In agreement with BizBio’s mission statement, Gina wants to assist students with finding the right career path following graduation. She is passionate about helping students and post-docs identify the “non-conventional” careers in the pharmaceutical/biotechnology industry and prepare them for the transition away from academia.
Tori earned her BS in Biochemistry with a minor in Pre-Medical Studies from Philadelphia University in 2017. Her undergraduate research focused on the extraction and purification of anthocyanins, and classification of their pharmacological effects. Currently she is a fourth year doctoral candidate in the Biochemistry and Molecular Pharmacology program. Her work in the lab of Erik Debler focuses on Trypanosoma brucei's chromatin dynamics, employing structural, biochemical, and enzymatic studies. Through BizBio’s programming, Tori is excited to aid students in exploring their career options.
Jenny earned her BS in Biochemistry from Mount St. Mary’s University in 2017. Before joining Jefferson, she was a research technologist at Johns Hopkins University, where she worked on projects identifying epigenetic biomarkers associated with chronic stress exposure. Currently, Jenny is a third-year PhD student in Dr. Lin Guo’s lab, where she studies protein phase separation of ALS/FTD-associated proteins. She is excited to begin her role as secretary, and she hopes to fulfill BizBio’s mission to provide Jefferson students the resources needed to find their career paths.
Elizabeth earned her BS in Chemistry from Temple University in 2019, where she was also a MARC U*STAR scholar. Her undergraduate research focused on understanding protein misfolding in achromatopsia II patients. Currently, she is a third year PhD student in the Biochemistry and Molecular Pharmacology program. Her thesis work in Dr. Charles Scott’s laboratory focuses on probing G𝜶12 as a novel therapeutic target to relieve bronchoconstriction. Elizabeth is passionate about exploring the connections between research and business to expand her knowledge about different scientific careers. Outside of the lab she enjoys taking care of her houseplants and volunteering.
Chair of Programming
Elana Molotsky graduated cum laude with distinction in research from Cornell University in 2017 where she received a B.S. in Biological Sciences and a minor in Cognitive Science. Currently, Elana is a doctoral candidate in the lab of Dr. Diane Merry studying motor neuron degeneration in spinal and bulbar muscular atrophy (SBMA). Elana is excited to help BizBio provide interesting and informative programming to Jefferson in the 2020-21 academic year.
Chair of Communications
Alexandra earned her BS in Quantitative Biology with minors in Chemistry and Biochemical Engineering from University of Delaware in 2019. Her undergraduate research focused on mathematical modeling of the ocular tear film. She is entering her third year as a PhD student in the Cell Biology and Regenerative Medicine program, working in the lab of Dr. Rajanikanth Vadigepalli. There she studies the regenerative mechanisms of the liver using both computational and systems biology research approaches. This year will be her first time serving as BizBio's Chair of Communications. In this role she looks forward to informing students about local job opportunities and helping students develop skills necessary for attaining their career goals.
Chair of Network Development
Viktoriia earned her BS in Chemistry with a minor in Business Administration, and MS in Organic Chemistry from Drexel University in 2020. Her Master’s Thesis work focused on small molecule drug development targeting certain cancer-associated proteins. Currently, she is a 1st year PhD student in the Biochemistry and Molecular Pharmacology program, active in her second rotation at Dr. Dmitry Temiakov’s lab, where she's focused on structural and functional studies on a novel RNA helicase. As an international student from Ukraine, Viktoriia aspires to help people step out of their comfort zone to network and socialize. She is passionate about exploring different ways to form and maintain professional connections which would put students on the right path toward their most desired careers.
Jeffrey I. Joseph, DO
Dr. Joseph is a Jefferson University Physician, Professor of Anesthesiology, and serial entrepreneur. His esteemed research career has focused on the development and commercialization of implantable medical devices for the management of diabetes and cardiovascular disease.
Dr. Joseph earned his Doctor of Osteopathic Medicine degree from the Philadelphia College of Osteopathic Medicine and completed residencies in general surgery, anesthesiology, and cardiac anesthesiology. His entrepreneurship began in 1994 when he co-invented an implantable device for glucose measurement using near-infrared light and optical sensors. With this technology, Dr. Joseph co-founded Animas Corporation to further develop and commercialize the device, as well as a complementary insulin infusion pump and catheter system. The company successfully completed an initial public offering on the Nasdaq Stock Exchange in 2004, and was subsequently acquired by Johnson & Johnson in 2006.
Recently, Dr. Joseph co-founded two more companies, Capillary Biomedical, Inc. and RTM Vital Signs, LLC. He currently serves as Chairman of the Scientific and Clinical Advisory Boards for both companies. Dr. Joseph has also served on advisory boards for seven other companies, as well as on numerous advisory committees for the federal government and private foundations.
Other current positions that Dr. Joseph holds include Vice-Chairman & Director of Research of the Department of Anesthesiology at Thomas Jefferson University & Hospital and Adjunct Professor in the School of Biomedical Engineering at Drexel University. He also founded the Jefferson Artificial Pancreas Center in 1998 and has served as its Director since. Dr. Joseph continues to lead a laboratory at TJU, improving upon novel insulin delivery systems.
Chad E. Beyer, PhD, MBA
Dr. Beyer has been the President & CEO of Promentis since early 2013. He is a pharmaceutical professional with nearly 20 years of experience in the research, discovery and business development of medications aimed to treat CNS and neurological disorders. For more than a decade, Dr. Beyer worked in the Discovery Neuroscience group at Wyeth Pharmaceuticals in Princeton, NJ, holding positions of increasing responsibility including serving as the Head of Neurochemistry and leading the Psychiatry Task Force. During his career at Wyeth, Dr. Beyer led several early-stage drug discovery teams, managed a group responsible for contributing to the submission of more than 30 INDs and provided supporting data for the commercialization and life-cycle management of two blockbuster medications: Effexor® and Pristiq®. Dr. Beyer holds a PhD in Neuropharmacology from LSU Medical Center and an MBA from the Rutgers Business School. Notably, Dr. Beyer has authored more than 70 manuscripts, obtained 3 patents, co-edited "Next Generation Antidepressants" and is co-founder of the journal Technology Transfer & Entrepreneurship. Dr. Beyer is also an adjunct faculty member at Thomas Jefferson University, where he teaches "Bioventure Management" and the business of doing science.
Dennis M. Gross, MS, PhD
Dr. Gross is currently the CEO and Treasurer of the Pennsylvania Drug Discovery Institute at the Pennsylvania Biotechnology Center. He is also Adjunct Faculty in the Jefferson College of Life Sciences and Professor of Experimental Therapeutics and Medicinal Chemistry at the Baruch S. Blumberg Institute of the Hepatitis B Foundation. He recently retired in 2014 from Jefferson, where he was the Associate Dean of the Jefferson College of Life Sciences and Associate Professor of Pharmacology & Experimental Therapeutics in the Sidney Kimmel Medical College. Prior to this, he was at the Merck Research Labs (MRL) for 29 years, retiring in 2006 as Senior Director and Head of West Point Business Operations with overall responsibilities for facilities in Pennsylvania, California and Massachusetts. He was also responsible for capital laboratory projects and operations oversight at MRL sites in the U.S., Canada, Japan, Italy and the UK. In his career at MRL he held a number of positions ranging from bench scientist to head of computer resources, manager of international strategic planning, M&A activities and liaison for basic research and clinical drug development in Japan.
During his tenure at MRL, he also served as Adjunct Professor of Global Logistics in the School of Business and Industry of Florida A&M University. He has worked with the Center for Strategic & International Studies in Washington, DC on policy issues relating to biological weapons of mass destruction. He received his BA (1969) and MS (1970) from California State University Northridge and his PhD (1974) from UCLA pursuing a postdoctoral fellowship at Tulane University School of Medicine.
Lisa Kozlowski, PhD
Dr. Kozlowski is the Associate Dean for Student and Postdoctoral Affairs at Thomas Jefferson University. She received her PhD in Immunology from the University of Pennsylvania and did a postdoctorate at the Johns Hopkins School of Medicine, where she was an officer in their postdoctoral association. She then worked as Program Director at Science's Next Wave, which is now part of ScienceCareers.org. She moved on to become a consultant, helping disciplinary societies and universities provide career workshops to their trainees.
Since October 2003, she has directed the Office of Postdoctoral Affairs at Thomas Jefferson University. Her administrative accomplishments include implementing a required minimum salary and revising the annual performance evaluation. Her enhancements for postdoctoral fellows include providing professional development workshops, establishing English as a Second Language (ESL) classes and co-organizing the annual Postdoctoral Research Symposium.
On the regional level, Lisa is a past president of the Philadelphia chapter of the Association for Women in Science. On the national level, she has been on the planning committee of the NPA annual meeting. She is also a past chair of the Postdoctorate Leaders Section Committee of the AAMC GREAT Group.